Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study - Medical Xpress

Medical Xpress

Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study Medical Xpress Most cancer drugs approved in Europe from 2009-2013 weren't backed by sufficient scientific evidence that they work, according to a new study. At the time of approval, around a third of European approvals were backed up by robust evidence from clinical ... Cancer patients need more than survivalThe Guardian Study Questions European Approval Process for Cancer DrugsDrug Discovery & Development Many new cancer drugs show 'no clear benefit', argues reviewNHS Choices Times of Malta -Science Daily -Deccan Chronicle -OZY all 88 news articles »

from Health - Google News http://ift.tt/2hRRmGs